In the world of science, there are many unsung heroes. One such hero is a person who worked in the pharmaceutical industry. Their job was to protect science from harmful policies. But their life changed when they faced a serious health issue. It all began with a bad backache. They ignored it at fir
Semaglutide, the star ingredient in weight-loss drugs Ozempic and Wegovy, just took a big hit. Two major trials showed it doesn't help people with early Alzheimer's or mild memory issues. Thousands of people aged 55 to 85 took part, but the results were clear: no improvement in memory or daily funct
Eli Lilly has decided to lower the prices of its weight loss drug, Zepbound, for people who pay out of pocket. This change is part of a bigger effort to make the medication more accessible to those who need it. The company announced that starting this week, the initial dose of Zepbound vials will co
Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.
Cindy Eckert, a woman who loves pink, is the CEO of Sprout Pharmaceuticals. Her company makes a drug called Addyi, which helps women with low sex drive. This condition is known as hypoactive sexual desire disorder (H. S. D. D. ). Addyi is often called the "little pink pill" and is different from Via
The stock market had a rollercoaster week, with the S&P 500 taking a hit but bouncing back. Investors are being cautious, especially with Big Tech's big spending and high valuations. Experts suggest sticking with companies that are actually making money, like Nvidia, Microsoft, and Alphabet, instead
Kimberly-Clark, a big name in consumer goods, just made a bold move. They bought Kenvue, the company behind Tylenol. But this deal didn't go over well with Wall Street. Their stock took a huge hit, the worst since the big crash in 1987. Shares dropped by 15%, which is a lot. Why did they do it? The
Metsera is at the center of a heated battle between two pharmaceutical giants, Pfizer and Novo Nordisk. It all started when Novo Nordisk made a surprising offer to buy Metsera for $6. 5 billion, even though Metsera had already agreed to a smaller deal with Pfizer. This has led to a legal fight, with
In August 2021, a high-ranking research executive left Lupin Inc. , a major drug company. He said he was moving to China to take care of his parents. But on his last day, he copied 128 company files before leaving. This act is now central to a legal battle. Lupin, based in India with U. S. operatio
China has been making big strides in the world of medicine. Since 2016, they've been approving new drugs at a faster pace. These drugs are called innovative because they are new and not sold anywhere else. The country's health authority, the NMPA, has been working hard to make sure these drugs get t
